Bidard FC - Search Results

1

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab.

Pierga JY, Bidard FC, Autret A, Petit T, Andre F, Dalenc F, Levy C, Ferrero JM, Romieu G, Bonneterre J, Lerebours F, Bachelot T, Kerbrat P, Campone M, Eymard JC, Mouret-Reynier MA, Gligorov J, Hardy-Bessard AC, Lortholary A, Soulie P, Boher JM, Proudhon C, Charafe-Jaufret E, Lemonnier J, Bertucci F, Viens P. Pierga JY, et al. Among authors: bidard fc. Ann Oncol. 2017 Jan 1;28(1):103-109. doi: 10.1093/annonc/mdw535. Ann Oncol. 2017. PMID: 28177480 Free article. Clinical Trial.

2

Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers.

Bidard FC, Conforti R, Boulet T, Michiels S, Delaloge S, André F. Bidard FC, et al. Ann Oncol. 2007 Jul;18(7):1285-6. doi: 10.1093/annonc/mdm360. Ann Oncol. 2007. PMID: 17675400 Free article. No abstract available.

3

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.

Bidard FC, Vincent-Salomon A, Sigal-Zafrani B, Diéras V, Mathiot C, Mignot L, Thiery JP, Sastre-Garau X, Pierga JY. Bidard FC, et al. Ann Oncol. 2008 Mar;19(3):496-500. doi: 10.1093/annonc/mdm507. Epub 2008 Jan 10. Ann Oncol. 2008. PMID: 18187488 Free article.

4

p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes.

Bidard FC, Matthieu MC, Chollet P, Raoefils I, Abrial C, Dômont J, Spielmann M, Delaloge S, André F, Penault-Llorca F. Bidard FC, et al. Ann Oncol. 2008 Jul;19(7):1261-1265. doi: 10.1093/annonc/mdn039. Epub 2008 Mar 5. Ann Oncol. 2008. PMID: 18325917 Free article.

5

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study.

Bidard FC, Tournigand C, André T, Mabro M, Figer A, Cervantes A, Lledo G, Bengrine-Lefevre L, Maindrault-Goebel F, Louvet C, de Gramont A. Bidard FC, et al. Ann Oncol. 2009 Jun;20(6):1042-7. doi: 10.1093/annonc/mdn730. Epub 2009 Jan 19. Ann Oncol. 2009. PMID: 19153116 Free article. Clinical Trial.

6

[Circulating tumor cells and breast cancer: detection techniques and clinical results].

Bidard FC, Saliba AE, Saias L, Degeorges A, Cremoux Pd, Viovy JL, Vincent-Salomon A, Mathiot C, Pierga JY, de Gramont A. Bidard FC, et al. Bull Cancer. 2009 Jan;96(1):73-86. doi: 10.1684/bdc.2008.0797. Bull Cancer. 2009. PMID: 19211362 Free article. Review. French.

7

Prognostic value of peripheral blood double detection of CK19 and MUC1 mRNA positive cells detected by RT-quantitative PCR in 94 breast cancer patients with a follow up of 9 years.

Pierga JY, Bidard FC, Denis MG, de Cremoux P. Pierga JY, et al. Among authors: bidard fc. Mol Oncol. 2007 Dec;1(3):267-8. doi: 10.1016/j.molonc.2007.09.005. Epub 2007 Sep 26. Mol Oncol. 2007. PMID: 19383302 Free PMC article. No abstract available.

8

Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer.

Bidard FC, Kirova YM, Vincent-Salomon A, Alran S, de Rycke Y, Sigal-Zafrani B, Sastre-Garau X, Mignot L, Fourquet A, Pierga JY. Bidard FC, et al. Ann Oncol. 2009 Nov;20(11):1836-41. doi: 10.1093/annonc/mdp200. Epub 2009 Jun 25. Ann Oncol. 2009. PMID: 19556319 Free article.

9

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer.

Bidard FC, Mathiot C, Delaloge S, Brain E, Giachetti S, de Cremoux P, Marty M, Pierga JY. Bidard FC, et al. Ann Oncol. 2010 Apr;21(4):729-733. doi: 10.1093/annonc/mdp391. Epub 2009 Oct 22. Ann Oncol. 2010. PMID: 19850639 Free article. Clinical Trial.

10

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

Bidard FC, Mathiot C, Degeorges A, Etienne-Grimaldi MC, Delva R, Pivot X, Veyret C, Bergougnoux L, de Cremoux P, Milano G, Pierga JY. Bidard FC, et al. Ann Oncol. 2010 Sep;21(9):1765-1771. doi: 10.1093/annonc/mdq052. Epub 2010 Mar 16. Ann Oncol. 2010. PMID: 20233745 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters